Mesoblast (MESO) Net Income towards Common Stockholders (2016 - 2024)
Historic Net Income towards Common Stockholders for Mesoblast (MESO) over the last 10 years, with Q4 2024 value amounting to -$47.9 million.
- Mesoblast's Net Income towards Common Stockholders fell 4731.25% to -$47.9 million in Q4 2024 from the same period last year, while for Jun 2025 it was -$113.0 million, marking a year-over-year increase of 3209.15%. This contributed to the annual value of -$102.1 million for FY2025, which is 1612.85% down from last year.
- Per Mesoblast's latest filing, its Net Income towards Common Stockholders stood at -$47.9 million for Q4 2024, which was down 4731.25% from -$32.5 million recorded in Q2 2024.
- Mesoblast's Net Income towards Common Stockholders' 5-year high stood at $15.3 million during Q1 2020, with a 5-year trough of -$76.8 million in Q1 2021.
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$32.5 million (2023), whereas its average is -$36.4 million.
- Per our database at Business Quant, Mesoblast's Net Income towards Common Stockholders tumbled by 60285.66% in 2021 and then soared by 7225.57% in 2022.
- Quarter analysis of 5 years shows Mesoblast's Net Income towards Common Stockholders stood at -$50.2 million in 2020, then skyrocketed by 48.04% to -$26.1 million in 2021, then plummeted by 58.48% to -$41.4 million in 2022, then grew by 21.35% to -$32.5 million in 2023, then tumbled by 47.31% to -$47.9 million in 2024.
- Its Net Income towards Common Stockholders stands at -$47.9 million for Q4 2024, versus -$32.5 million for Q2 2024 and -$32.5 million for Q4 2023.